Table 1.
Demographics of overall cohort of patients with CRC compared to subset of patients with HER2-amplified CRC.
| Characteristic | Patients with CRC | Patients with HER2-amplified CRC | |
|---|---|---|---|
| Age: median [IQR] | 63 [52–72] | 63 [50–77] | |
| Gender | Male | 55.6% (2683/4823) | 66.7% (82/123) |
| Female | 44.4% (2140/4823) | 33.3% (41/123) | |
| Race | Black | 11.2% (298/2651) | 12.0% (9/75) |
| Asian | 8.6% (228/2651) | 12.0% (9/75) | |
| White | 79.9% (2118/2651) | 76.0% (57/75) | |
| Other | 0.3% (7/2651) | 0.0% (0/75) | |
| Cancer location | Colon | 69.9% (2360/3375) | 70.1% (61/87) |
| Rectum | 30.1% (1015/3375) | 29.9% (26/87) | |
Abbreviations: CRC, colorectal cancer; IQR, interquartile range; HER2, human epidermal growth factor receptor-2.